Capricor Therapeutics Inc (CAPR)

[dia76ca]

What does Capricor's financial situation look like in 2026?
* It has about $300 million cash on hand.
* With Deramiocel approval it will receive $80 million from a NS milestone and a PRV worth at least $150 million.
* They have hundreds of millions due in upfront and milestones from NS when Deramiocel is advanced in Japan.
* There will be hundreds of millions due in upfront and milestones when they sign an European/ROW partnership with NS or a Big Pharma.
* There will be Deramiocel revenue in the US beginning in 2026. And there will be sales milestones from NS !
* They have said that they intend to partner the exosome based products from the StealthX PLATFORM. Will they have many partners with many products? Or will there be one large partnership with Big Pharma ?
Either way there will be upfront, milestone and royalty revenues starting in 2026.
CAPRICOR has a solid financial base in 2026. And it will only get stronger year after year.